Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.82%81.21M | 114.53%341.8M | 90.28M | 304.41%87.67M | 121.01%83.56M | 307.66%78.99M | 48.31%159.33M | -1.60%21.68M | -42.29%107.43M | -71.40%28.22M |
| Cost of revenue | -11.09%52.18M | 95.61%211.07M | 56.42M | 289.46%59.03M | 160.68%55.78M | 357.92%58.69M | 65.04%107.9M | 2.79%15.16M | -48.71%65.38M | -79.61%16.42M |
| Gross profit | 43.05%29.03M | 154.21%130.73M | 33.86M | 339.16%28.64M | 69.30%27.79M | 209.45%20.29M | 22.29%51.43M | -10.49%6.52M | -28.38%42.05M | -34.97%11.8M |
| Operating expense | 35.56%16.07M | -42.43%92.99M | 19.12M | -46.93%15.92M | 40.43%18.09M | -13.88%11.85M | 185.90%161.52M | 106.35%30.01M | -21.90%56.5M | -69.11%15.31M |
| Selling and administrative expenses | 38.96%15.77M | -42.43%92.99M | --19.9M | -48.73%15.55M | 42.19%17.21M | -10.01%11.35M | 204.53%161.52M | 117.63%30.33M | -26.68%53.04M | -73.61%14.39M |
| -General and administrative expense | 38.96%15.77M | -42.43%92.99M | --19.9M | -48.73%15.55M | 42.19%17.21M | -10.01%11.35M | 204.53%161.52M | 117.63%30.33M | -26.68%53.04M | -73.61%14.39M |
| Depreciation and amortization | 2.49%1.03M | --4.07M | --1.15M | -56.98%776K | -7.39%1.14M | -22.13%1M | ---- | 73.96%1.8M | --4.61M | 88.26%1.06M |
| -Depreciation | 2.49%1.03M | --4.07M | --1.15M | -56.98%776K | -7.39%1.14M | -22.13%1M | ---- | 73.96%1.8M | --4.61M | 88.26%1.06M |
| Total other operating income | 46.40%732K | --3.1M | --1.93M | -81.04%403K | -42.20%263K | 264.96%500K | ---- | 393.27%2.13M | --1.16M | -97.58%133K |
| Operating profit | 53.56%12.97M | 134.28%37.74M | 14.74M | 154.15%12.72M | 174.60%9.7M | 217.22%8.44M | -662.23%-110.1M | -223.66%-23.49M | -6.04%-14.44M | 88.82%-3.52M |
| Net non-operating interest income (expenses) | -75.45%-1.45M | -39.28%-7.05M | -2.46M | 38.15%-1.81M | -280.33%-1.14M | -546.09%-827K | -289.41%-5.06M | -796.63%-2.92M | 24.06%-1.3M | 35.84%-546K |
| Non-operating interest expense | 75.45%1.45M | 39.28%7.05M | --2.46M | -38.15%1.81M | 280.33%1.14M | 546.09%827K | 289.41%5.06M | 796.63%2.92M | -24.06%1.3M | -35.84%546K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 95.11%-7.16M | -146.46M | ||||||||
| Less:Impairment of capital assets | ---- | -92.93%4.76M | ---- | ---- | ---- | ---- | --67.3M | ---- | ---- | ---- |
| Less:Write off | ---- | -96.96%2.41M | ---- | ---- | ---- | ---- | --79.16M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -88.89%14.27M | 128.44M | ||||||||
| Income before tax | 51.18%11.51M | 128.38%37.8M | 12.28M | 141.31%10.91M | 164.78%8.56M | 203.89%7.62M | -745.89%-133.18M | -248.30%-26.41M | 52.52%-15.74M | 87.42%-4.06M |
| Income tax | 199.79%2.81M | 63.44%6.62M | 1.41M | 498.21%2.44M | -68.67%470K | 936K | 189.19%4.05M | -26.92%-613K | 528.31%1.4M | 322.67%383K |
| Net income | 30.36%8.71M | 122.72%31.18M | 10.87M | 132.83%8.47M | 367.07%8.09M | 191.12%6.68M | -700.43%-137.23M | -263.36%-25.8M | 47.78%-17.14M | 86.16%-4.44M |
| Net income continuous operations | 30.36%8.71M | 122.72%31.18M | --10.87M | 132.83%8.47M | 367.07%8.09M | 191.12%6.68M | -700.43%-137.23M | -263.36%-25.8M | 47.78%-17.14M | 86.16%-4.44M |
| Noncontrolling interests | 90.03%2.57M | 249.29%4.95M | 2.44M | 105.07%121K | 100,850.00%2.02M | 1,081.16%1.35M | -249.41%-3.32M | -701.34%-2.39M | 64.53%-949K | 79.20%-512K |
| Net income attributable to the company | 15.19%6.14M | 119.59%26.23M | 8.44M | 135.66%8.35M | 250.26%6.07M | 174.04%5.33M | -726.86%-133.91M | -244.17%-23.41M | 46.29%-16.2M | 86.74%-3.93M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 15.19%6.14M | 119.59%26.23M | 8.44M | 135.66%8.35M | 250.26%6.07M | 174.04%5.33M | -726.86%-133.91M | -244.17%-23.41M | 46.29%-16.2M | 86.74%-3.93M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 4.67%0.0112 | 108.48%0.052 | 0.0222 | 110.77%0.0167 | 103.33%0.0122 | 141.47%0.0107 | -953.26%-0.613 | -530.08%-0.155 | 46.41%-0.0582 | 86.52%-0.0144 |
| Diluted earnings per share | 4.67%0.0112 | 108.48%0.052 | 0.0222 | 110.77%0.0167 | 103.33%0.0122 | 141.47%0.0107 | -953.26%-0.613 | -530.08%-0.155 | 46.41%-0.0582 | 86.52%-0.0144 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.